EPOPROSTENOL
DrugBank ID: db01240
DrugCentral: epoprostenol
Synonymous :(5z,13e)-(15s)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate | (5z,9α,11α,13e,15s)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid | epoprostenol | pgi2 | pgx | prostacyclin | prostaglandin i2 | prostaglandin x | vasocyclin
Drug Sentece Context
Table 1. Analysis of context sentence of epoprostenol gene in 3 abstracts.
| pmid | sentence |
|---|---|
| 32324366 | Inhalational nitric oxide (iNO), inhalational epoprostenol and veno-venous extracorporeal membrane oxygenation (ECMO) are options in severe hypoxemia that is unresponsive to conventional mechanical ventilation. |
| 32852238 | Interruptions in continuous nebulized pulmonary vasodilators, such as epoprostenol, can potentially result in clinical deterioration in respiratory status. […] In this study, we describe a unique method of administering continuous epoprostenol nebulization and intermittent nebulized antibiotics, mucolytics, and bronchodilators, using Aerogen vibrating mesh nebulizers without interruptions in epoprostenol or opening the ventilator circuit. |
| 32984987 | Our study revealed that only cilostazol has the most favorable binding interaction on Mpro (PDB ID: 6LU7) and cilostazol, iloprost, epoprostenol, prasugrel, and icosapent ethyl have a higher binding affinity on spike glycoprotein (S) (PDB ID: 6VYB) compared with recent anti-CoVID-19. |